
Rivastigmine Patch Suppliers & Bulk Manufacturers
Available Forms: Transdermal patches
Available Strengths: 4.6 mg/24 hr and 9.5 mg/24 hr patches
Reference Brands: Exelon
Category: Transdermal Patches
Rivastigmine Patch is available in Transdermal patches and strengths such as 4.6 mg/24 hr and 9.5 mg/24 hr patches. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Rivastigmine Patch is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Rivastigmine Patch can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description:
Rivastigmine patches are regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality per GMP standards. In the US, FDA approval involved clinical validation, safety assessments, and GMP compliance. In the EU, CE marking certifies conformity with MDR standards. These devices undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring regulatory compliance guarantees access to reliable, effective rivastigmine transdermal systems, supporting improved management of dementia symptoms worldwide and facilitating safe, regulated treatment options for patients with cognitive decline.
Frequently Asked Questions
Related Products
Rotigotine Patch
Strength: 2 mg/24 hr, 4 mg/24 hr, 6 mg/24 hr, 8 mg/24 hr, and 12 mg/24 hr
Form: Patches
Reference Brands: Neupro
View DetailsSelegiline Patch
Strength: 6 mg/24 hr, 9 mg/24 hr, and 12 mg/24 hr patches
Form: Patches
Reference Brands: Emsam
View Details.Scopolamine Patch
Strength: 1.5 mg patch
Form: Patches
Reference Brands: Transderm-Scop
View DetailsQuick Response Guaranteed | Verified Suppliers